Standard BioTools Inc.

LAB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-19.1M
Depreciation & Amortization $1.6M
Depreciation
Amortization
Stock-Based Compensation $2.1M
Net Cash from Operating Activities $-19.5M
Investing Activities
Capital Expenditures $799.0K
Business Acquisitions
Net Cash from Investing Activities $-688.0K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $16.9M
Net Change in Cash $-3.2M
Free Cash Flow $-20.3M
← Newer Page 3 of 3 Older →